Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Registrati

Quotazioni in diretta

LEGN Legend Biotech Corporation

45,02

0,00 (0,00%)

Pre Mercato

Ultimo aggiornamento: 12:00:01

Dati in Delay di 15 minuti

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

09/20/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Eric Janiak, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Yau Wai Man Philip

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Grafico Azioni Legend Biotech (NASDAQ:LEGN)
Storico
Da Ott 2024 a Nov 2024

Clicca qui per i Grafici di Legend Biotech

Grafico Azioni Legend Biotech (NASDAQ:LEGN)
Storico
Da Nov 2023 a Nov 2024

Clicca qui per i Grafici di Legend Biotech

Notizie Legend Biotech Corporation - LEGN

Legend Biotech to Host Investor Conference Call on Third Quarter 2024 Results
Giovedì 24 Ottobre 2024 (1 settimana fa) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martedì 22 Ottobre 2024 (1 settimana fa) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Lunedì 21 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martedì 15 Ottobre 2024 (2 settimane fa) • Edgar (US Regulatory)

Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
Giovedì 3 Ottobre 2024 (4 settimane fa) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Venerdì 27 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
Venerdì 27 Settembre 2024 (1 mese fa) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Mercoledì 25 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 20 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Venerdì 20 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Venerdì 20 Settembre 2024 (1 mese fa) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Martedì 27 Agosto 2024 (2 mesi fa) • Edgar (US Regulatory)

Più Legend Biotech Corporation Articoli Notizie

Delayed Upgrade Clock

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US ADVFN Korea